Training Programs that Generate Leaders
Trainees benefit from strong mentorship and exposure to all subspecialties.
Our Research:
Bold and Broad
One of the nation’s largest ophthalmology & visual sciences research faculty drives innovation across the field through a highly multidisciplinary approach.
Sub-specialty and comprehensive care
for a diverse population
9,000+ procedures a year
11,000+ surgeries a year
165,000+ patient visits a year
Nationally ranked hospital partners:
Innovative Clinical Trials for Advanced Eye Care
Driving progress in vision science with groundbreaking research studies.
Latest News
Advancing AMD Research: Apte Addresses Congress
Macular Degeneration: A Leading Cause of Vision Loss Age-related macular degeneration (AMD) is the leading cause of blindness in adults over 50 in North America, affecting nearly 20 million Americans today. Globally, that number is projected to reach 300 million by 2040, with nearly two million people in the U.S. living with severe vision loss. […]
Installation Ceremony for Aaron Y Lee, MD, MSCI
Arthur W. Stickle Distinguished Professor of Ophthalmology and Visual Sciences On February 11, the WashU Medicine John F. Hardesty, MD Department of Ophthalmology & Visual Sciences community gathered to honor Aaron Y. Lee, MD, MSCI as the newly installed Arthur W. Stickle Distinguished Professor of Ophthalmology & Visual Sciences. The installation ceremony, featured Lee’s compelling […]
Julia Pulliam, OD, FAAO Presents on Collaborative Uveitis Care at Envision Summit
The WashU Medicine John F. Hardesty, MD Department of Ophthalmology & Visual Sciences is proud to share that Julia Pulliam, OD, FAAO, recently presented at the Envision Summit in Puerto Rico. Her presentation focused on “Collaborating (OD/MD) in Uveitis Patients,” highlighting the power of interdisciplinary care in managing complex inflammatory eye disease. Uveitis often requires […]
Advancing Hope for Patients With Age-Related Macular Degeneration
Age-related macular degeneration (AMD) remains the leading cause of blindness in adults over age 50, and while treatments exist for advanced stages of the disease, they are not curative or preventive. During Low Vision and AMD Awareness Month, researchers in the Rajendra S. Apte, MD, PhD and the Apte Lab within the WashU Medicine John […]
New Clinical Trial Awarded to Study Geographic Atrophy in Age-Related Macular Degeneration
The WashU Medicine John F. Hardesty, MD Department of Ophthalmology & Visual Sciences has received a notice of award for a new clinical trial focused on advancing treatment options for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The study, titled “Efficacy of Dapagliflozin in Geographic Atrophy Secondary to Age-Related Macular Degeneration: […]
Upcoming Events
-
6
Mar -
11
Mar -
12
Mar